SPONSOR
Tan Jie
Total Trials
1
Recruiting
1
Phases
EARLY_Phase 1
Conditions studied: Acute Lymphoblastic Leukemia
Tan Jie is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Acute Lymphoblastic Leukemia.
The trial portfolio spans EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Tan Jie
How many clinical trials has Tan Jie sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Tan Jie, of which 1 are actively recruiting participants. These trials cover conditions including Acute Lymphoblastic Leukemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Tan Jie research focus on?
Tan Jie clinical trials span Acute Lymphoblastic Leukemia. The research pipeline includes EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Tan Jie clinical trial?
To participate in a Tan Jie trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Tan Jie trials with current recruitment status updated daily.
Clinical Trials by Tan Jie
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology